Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/42793| Title: | Triple intraventricular chemotherapy for treatment of relapsed choroid plexus carcinoma. [Pediatric Blood and Cancer] | Authors: | Lau G.;Drummond J.;Zhukova N.;Wood P. ;Janson L. | Institution: | (Lau, Drummond, Janson) Pharmacy Department, Monash Health, Clayton, VIC, Australia (Zhukova, Wood) Children's Cancer Centre, Monash Children's Hospital/Monash Health, Clayton, VIC, Australia (Zhukova, Wood) Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, VIC, Australia (Wood) Department of Paediatrics, Monash University, VIC, Australia |
Issue Date: | 12-Aug-2021 | Copyright year: | 2021 | Publisher: | John Wiley and Sons Inc | Place of publication: | United States | Publication information: | Pediatric Blood and Cancer. 68 (9) (no pagination), 2021. Article Number: e29094. Date of Publication: September 2021. | Journal: | Pediatric Blood and Cancer | DOI: | http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1002/pbc.29094 | PubMed URL: | 34003555 [http://www.ncbi.nlm.nih.gov/pubmed/?term=34003555] | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/42793 | Type: | Letter | Subjects: | brain cancer/di [Diagnosis] brain cancer/dt [Drug Therapy] brain cancer/rt [Radiotherapy] cancer growth cancer palliative therapy cancer recurrence choroid plexus tumor/di [Diagnosis] choroid plexus tumor/dt [Drug Therapy] choroid plexus tumor/rt [Radiotherapy] DNA methylation drug megadose fatigue/si [Side Effect] histopathology induction chemotherapy minimal residual disease multiple cycle treatment nausea/dt [Drug Therapy] nausea/si [Side Effect] palliative therapy personalized medicine promoter region school triplet chemotherapy tumor vascularization carboplatin/pv [Special Situation for Pharmacovigilance] celecoxib/cb [Drug Combination] celecoxib/dt [Drug Therapy] celecoxib/pv [Special Situation for Pharmacovigilance] cisplatin/cb [Drug Combination] cisplatin/dt [Drug Therapy] cisplatin/pv [Special Situation for Pharmacovigilance] cyclophosphamide/cb [Drug Combination] cyclophosphamide/dt [Drug Therapy] cyclophosphamide/pv [Special Situation for Pharmacovigilance] etoposide/ae [Adverse Drug Reaction] etoposide/cb [Drug Combination] etoposide/dt [Drug Therapy] etoposide/cv [Intracerebroventricular Drug Administration] etoposide/pv [Special Situation for Pharmacovigilance] fenofibrate/cb [Drug Combination] fenofibrate/dt [Drug Therapy] fenofibrate/pv [Special Situation for Pharmacovigilance] methotrexate/cb [Drug Combination] methotrexate/dt [Drug Therapy] methotrexate/pv [Special Situation for Pharmacovigilance] methylated DNA protein cysteine methyltransferase/ec [Endogenous Compound] ondansetron/dt [Drug Therapy] ondansetron/pv [Special Situation for Pharmacovigilance] protein p53/ec [Endogenous Compound] thalidomide/cb [Drug Combination] thalidomide/dt [Drug Therapy] thalidomide/pv [Special Situation for Pharmacovigilance] thiotepa/ae [Adverse Drug Reaction] thiotepa/cb [Drug Combination] thiotepa/dt [Drug Therapy] thiotepa/cv [Intracerebroventricular Drug Administration] thiotepa/pv [Special Situation for Pharmacovigilance] topotecan/ae [Adverse Drug Reaction] topotecan/cb [Drug Combination] topotecan/dt [Drug Therapy] topotecan/cv [Intracerebroventricular Drug Administration] topotecan/pv [Special Situation for Pharmacovigilance] vincristine/cb [Drug Combination] vincristine/dt [Drug Therapy] vincristine/pv [Special Situation for Pharmacovigilance] Ommaya reservoir |
Type of Clinical Study or Trial: | Case series or case report |
| Appears in Collections: | Articles |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.